Integra LifeSciences reported total revenues for the second quarter of 2010 as $178.6 million, reflecting an 8 percent increase over the second quarter of 2009, according to a company news release.
The strong quarterly profits Integra LifeSciences reported can be attributed to strong sales in the orthopedics and neurosciences segments.
Adjusted EBITDA was $35.5 million, up two percent from the second quarter last year.
Integra also reported a GAAP net income of $15.2 million and an adjusted net income of $20.9 million for the second quarter of 2010. The company generated $19.4 million in cash flow from operations and used $5.7 million of cash on capital expenditures.
Read the news release on the second quarter for Integra LifeSciences.
Read more coverage on Integra LifeSciences:
- Integra LifeSciences Announces Milestone for Vu a-POD Device
- Integra LifeSciences Launches Dura Repair Product
- Integra LifeSciences Reports $11M Increase in Q1 Revenues
The strong quarterly profits Integra LifeSciences reported can be attributed to strong sales in the orthopedics and neurosciences segments.
Adjusted EBITDA was $35.5 million, up two percent from the second quarter last year.
Integra also reported a GAAP net income of $15.2 million and an adjusted net income of $20.9 million for the second quarter of 2010. The company generated $19.4 million in cash flow from operations and used $5.7 million of cash on capital expenditures.
Read the news release on the second quarter for Integra LifeSciences.
Read more coverage on Integra LifeSciences:
- Integra LifeSciences Announces Milestone for Vu a-POD Device
- Integra LifeSciences Launches Dura Repair Product
- Integra LifeSciences Reports $11M Increase in Q1 Revenues